Vitestro
Netherlands - UtrechtBiotechnology
Focus: Vitestro is a Netherlands-based biotech company developing automated blood draw technology, specifically robotic venipuncture devices to transform phlebotomy. The company operates at mid-stage with 51–200 employees and is preparing for commercial launch in 2027.
Profile data last refreshed 6h ago · AI intelligence enriched 3w ago
Employees
51-200
Open Jobs
3-1 this month
Stable — net -1 jobs in 30d
2 added, 3 removed. Backfill posture.
Should You Work at Vitestro?
AI assessmentVitestro is a high-risk, high-upside medtech play suitable for innovation-focused professionals comfortable with execution risk and regulatory uncertainty.
Why Work Here
- Recent $70M funding round (March 2026) signals strong investor confidence and near-term runway for growth hiring and product commercialization.
- Entry into a novel, high-impact medtech category (robotic phlebotomy) offers opportunity to shape an emerging market rather than compete in crowded spaces.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Venipuncture Device
VenipunctureClinical Trials (1)
NCT05878483Autonomous Blood Drawing Optimization and Performance Testing
N/AHelp build intelligence for Vitestro
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.